Xanthohumol inhibits angiogenesis by suppressing nuclear factor‐κB activation in pancreatic cancer

E-ISSN： 1349-7006|109|1|132-140

ISSN： 1347-9032

Source： Cancer Science, Vol.109, Iss.1, 2018-01, pp. : 132-140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Retinoid X receptor α enhances human cholangiocarcinoma growth through simultaneous activation of Wnt/β‐catenin and nuclear factor‐κB pathways

Cancer Science, Vol. 106, Iss. 11, 2015-11 ,pp. : 1515-1523

John Wiley & Sons Inc

Access to resources Recommend Favorite

Oncogenic activity of BIRC2 and BIRC3 mutants independent of nuclear factor‐κB‐activating potential

Cancer Science, Vol. 1347-9032, Iss. 9, 2015-09 ,pp. : 1137-1142

John Wiley & Sons Inc

Access to resources Recommend Favorite

Oncogenic activity of BIRC2 and BIRC3 mutants independent of nuclear factor‐κB‐activating potential

Cancer Science, Vol. 106, Iss. 9, 2015-09 ,pp. : 1137-1142

John Wiley & Sons Inc

Access to resources Recommend Favorite

Molecular Mechanism on Inhibition of MB Angiogenesis by Curcumin Blocking the Wnt/β-Catenin and NF-κB Signaling Pathway and Inhibiting the Expression of VEGFs/VEGFRs

Advanced Materials Research, Vol. 2015, Iss. 1120, 2015-08 ,pp. : 798-802

Trans Tech Publications

Access to resources Recommend Favorite

Fibrinogen‐derived fibrinostatin inhibits tumor growth through anti‐angiogenesis

Cancer Science, Vol. 106, Iss. 11, 2015-11 ,pp. : 1596-1606

John Wiley & Sons Inc

Access to resources Recommend Favorite